Fundacion Sales
Records under this name other than the patents Fundacion Sales holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 6 of 6 · Back to Fundacion Sales
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,968,740 | Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 No holder on record In force · High confidence | In force | High confidence | |
| US 10,456,465 | Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 Held by another company In force · Medium confidence | In force | Medium confidence | |
| US 11,723,972 | Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using GALECTIN-1 Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,939,428 | Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Immune Disorders Using GALECTIN-1 Lapsed on the fee record Ended Apr 10, 2026 · High confidence | Lapsed on the fee record | Ended Apr 10, 2026 | High confidence |
| US 9,045,523 | Compounds Lapsed on the fee record Ended Jun 2, 2023 · USPTO record | Lapsed on the fee record | Ended Jun 2, 2023 | USPTO record |
| US 6,808,924 | Mouse mammary tumor lines expressing estrogen and progesterone receptors Term ended Term ended Jul 11, 2020 · USPTO record | Term ended | Term ended Jul 11, 2020 | USPTO record |